Categories AlphaGraphs, Earnings, Health Care
Infographic: Highlights of Abbott Laboratories’ (ABT) Q4 2023 earnings report
Abbott Laboratories (NYSE: ABT), a diversified healthcare services company, Wednesday reported its fourth quarter 2023 financial results.
Net income, excluding special items, increased to $1.19 per share in the fourth quarter from $1.03 per share in the corresponding period of last year. Unadjusted net income was $1.59 billion or $0.91 per share in Q4, compared to $1.03 billion or $0.59 per share in the fourth quarter of 2022.
Fourth-quarter sales increased 1.5% year-over-year to $10.24 billion. Organic sales growth for the underlying base business increased by 11.0%.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
